Back
CVE-2020-7285
Privilege Escalation vulnerability in MVISION Endpoint
High7.8EPSS 0.25%
- Published
- Updated
- Reserved
- Assigned by
- trellix
Description
Privilege Escalation vulnerability in McAfee MVISION Endpoint prior to 20.5.0.94 allows a malicious script or program to perform functions that the local executing user has not been granted access to.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| trellixCNA (assigner) | 3.1 | High7.8 | CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H |
| NVDNVD · Modified | 3.1 | High7.8 | CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
- EPSS (exploitation in 30 days)
- 0.25% · top 83% of all CVEs (6 Nov 2026)
Loading the EPSS history…
The list uses the assigner's score when there is one, then CISA's, then NVD's: High 7.8.
Weakness
Affected products
McAfee,LLC · McAfee MVISION Endpoint
- affected 20.x – < 20.5.0.94
References (1)
- https://kc.mcafee.com/corporate/index?page=content&id=SB10317 (opens in a new tab)x_refsource_CONFIRMx_transferred
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://trackcve.app/cve/CVE-2020-7285)Record last updated .